Clinical Trials Browser

Phase 1/2 × Lung Neoplasms × Radiotherapy, Conformal × Clear all

NCT00280150 2017-06-19

Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer

Phase 1/2 Completed

46 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms